New investment from the ADDF’s Diagnostics Accelerator leads efforts to develop standardization materials for leading diagnostic biomarker: New York Saturday, November 16, 2024, ...
Avant Technologies, Inc. is an emerging technology company developing solutions in artificial intelligence in healthcare.
LAS VEGAS, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”), and Ainnova Tech, Inc., (Ainnova) a leading ...
A study by the UCSF Weill Institute for Neurosciences found that retinal scans can identify blood vessel changes indicative ...
as well as diseases unrelated to the retina like cardiovascular disease and potentially even Alzheimer’s with high accuracy and speed using retinal scans. Meanwhile, Ainnova’s next-generation ...
as well as diseases unrelated to the retina like cardiovascular disease and potentially even Alzheimer's with high accuracy and speed using retinal scans. Meanwhile, Ainnova's next-generation ...
Alzheimer's researchers are widening the scope of biomarkers used to detect Alzheimer's and dementia. In a recent research update, the Alzheimer's Association a ...
As we count down toward the December readout of Cassava Sciences’ simufilam Phase 3 clinical trial in Alzheimer’s disease, it ...
An 80-something patient came in for an annual visit recently and was worried that recent memory lapses might be symptoms of Alzheimer’s ... a PET scan or a spinal fluid test.